Aramark director receives 199 share-equivalent stock award

SADOVE STEPHEN I reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 06/04/2026 - 06:28 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

SADOVE STEPHEN I reported acquisition or exercise transactions in this Form 4 filing.

Aramark director Stephen I. Sadove reported routine equity compensation changes. He received 199.022 shares of common stock at no cost, representing dividend equivalent rights that accrued on his deferred stock units and vest on the same schedule as the underlying awards. Following this grant, he directly holds 102,506.767 common shares and indirectly holds 15,000 shares through a trust.

Insider Trade Summary

Grant/Award: 199.022 shares

Grant/Award 1 txn

Insider SADOVE STEPHEN I

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	199.022	$0.00	$0.00
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 102,506.767 shares (Direct); Common Stock — 15,000 shares (Indirect, By Trust)

Holdings Before and After: Common Stock, 102,307.745 to 102,506.767 shares (Direct)

Footnotes (1)

1. F1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Key Figures

Dividend equivalent rights granted: 199.022 shares Grant price per share: $0.0000 per share Direct holdings after transaction: 102,506.767 shares +3 more

6 metrics

Dividend equivalent rights granted 199.022 shares Common Stock grant coded as award on 2026-06-03

Grant price per share $0.0000 per share Price for 199.022 dividend equivalent rights

Direct holdings after transaction 102,506.767 shares Common Stock directly owned by Stephen I. Sadove

Indirect trust holdings 15,000 shares Common Stock held indirectly by trust

Transaction code A Grant, award, or other acquisition of common stock

Acquire transactions count 1 transaction Non-derivative acquisition reported in transactionSummary

Key Terms

dividend equivalent rights, deferred stock units, grant, award, or other acquisition, indirect ownership

4 terms

dividend equivalent rights financial

"Represents dividend equivalent rights in connection with the Issuer's quarterly dividend"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

deferred stock units financial

"accrued to the reporting person on deferred stock units held by the reporting person"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

grant, award, or other acquisition regulatory

"transaction_code_description": "Grant, award, or other acquisition""

indirect ownership financial

""ownership_type": "indirect", "ownership_code": "I""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Aramark (ARMK) director Stephen Sadove report on this Form 4?

Stephen I. Sadove reported an acquisition of 199.022 Aramark common shares as dividend equivalent rights on deferred stock units. These rights were granted at no cost and vest on the same schedule as the related awards, reflecting routine equity-based compensation adjustments.

How many Aramark (ARMK) shares does Stephen Sadove hold after this filing?

After the reported transactions, Stephen I. Sadove directly holds 102,506.767 Aramark common shares. He also has an indirect holding of 15,000 shares through a trust, giving investors a clearer view of his total reported equity exposure to the company.

What is the nature of the 199.022 Aramark (ARMK) shares reported on Form 4?

The 199.022 shares are dividend equivalent rights tied to Aramark’s quarterly dividend, accruing on Sadove’s deferred stock units. They were granted at a price of $0.0000 per share and will vest according to the same schedules as the underlying deferred stock unit awards.

Were there any open-market buys or sells by Stephen Sadove in this Aramark (ARMK) Form 4?

No open-market purchases or sales were reported. The filing shows an acquisition coded as a grant or award and a separate holding entry for indirectly owned shares through a trust, indicating routine equity compensation and ownership reporting rather than trading activity.

How are Stephen Sadove’s indirect Aramark (ARMK) holdings structured?

Sadove reports 15,000 Aramark common shares as indirect ownership held "By Trust." This indicates the shares are owned through a trust arrangement, which is disclosed separately from his 102,506.767 directly held shares to clarify the nature of his beneficial holdings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SADOVE STEPHEN I

(Last) (First) (Middle)

C/O ARAMARK

2400 MARKET STREET

(Street)

PHILADELPHIA PENNSYLVANIA 19103

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/03/2026		A		199.022(1)	A	$0	102,506.767	D
Common Stock								15,000	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)